Viral suppression in the era of transition to dolutegravir-based therapy in Cameroon: Children at high risk of virological failure due to the lowly transition in pediatrics

J Fokam, AD Nka, FY Dzukam, JE Gabisa, Y Bouba, MCT Tchouaket, AC Ka'e, ENJ Semengue, D Takou, S Moudourou, N Fainguem, W Pabo, RAN Mundo, AMK Ngueko, CA Chenwi, JF Yimga, MKN Zam, RS Kamgaing, C Tangimpundu, N KamgaingAE Njom-Nlend, PN Koki, D Kesseng, SN Tetang, E Kembou, LE Lifanda, B Pamen, A Ketchaji, ES Temgoua, SC Billong, ACZK Bissek, H Hadja, EG Halle, V Colizzi, CF Perno, SM Sosso, A Ndjolo

Research output: Contribution to journal › A1: Web of Science-article › peer-review

Fingerprint

Dive into the research topics of 'Viral suppression in the era of transition to dolutegravir-based therapy in Cameroon: Children at high risk of virological failure due to the lowly transition in pediatrics'. Together they form a unique fingerprint.

Medicine & Life Sciences